TGFB1 and eosinophilic esophagitis: Currently, a clinical trial for EoE is examining the effect of losartan, an angiotensin II receptor blocker used clinically for hypertension that also exerts anti-fibrotic effect through suppression of active TGFβ1 levels (126).